We exhibited at Bio Japan (October 8-10, at Pacifico Yokohama) and the Japanese Society for Extracellular Vesicles (JSEV) (October 14-15, at Osaka). We introduced our business activities to date and exhibited related topics, and on both occasions we were able to explain to the many visitors, leading to lively Q&A sessions and information exchanges. We were also able to obtain many business leads that could potentially lead to future business development. We would like to once

We are currently exhibiting at a booth at BioJapan, which is being held at Pacifico Yokohama. Please stop by when you visit. [BioJapan...

We are planning to exhibit at a booth at BioJapan, which will be held at Pacifico Yokohama from Wednesday, October 8th to Friday, October...

The highly sensitive protein quantification technology "TN-cyclon™ ELISA Kit" developed and provided by BioPhenoMA Co., Ltd. has been...

BioPhenoMA Inc. (headquarters: Shinjuku-ku, Tokyo) is pleased to announce that Director Makoto Mitamura has been appointed as the new...

A paper on the establishment of an ultrasensitive detection assay for sEV-derived PD-L1 as a serum biomarker for lung cancer - a pilot...

Sales of the "TN-cyclon™ ELISA Development Kit" have begun. Order page: https://www.funakoshi.co.jp/contents/72027 [Please visit the...

Funakoshi Co., Ltd. sells PD-L1 measurement kits using TN-cyclon™ technology, as well as kits for ultra-low-volume protein analysis...

BioPhenoMA launches the new ultra-sensitive protein detection reagent kit (Product Name: “TN-cyclon™ ELISA Development Kit”) for research...

The Article about our new reagent kit for research was published in The Nikkan Kogyo Shimbun. Read the article (Japanese):...

Journal of Cellular Immunology Vol. 7 (January issue) published our article “ GRP78: A Multifaceted Role in Cancer Progression and...

BioPhenoMA has been selected as one of the companies in the Health category of the Winter/Spring 2025 Q1 Batch accelerator program by...

Frontiers in Immunology Vol. 15 (December issue) published our article “Ultrasensitive protein-level detection for respiratory infectious...

BioPhenoMA launches the ultra-sensitive PD-L1 detection reagent kit (Product Name: “PD-L1 TN-cyclon™ ELISA Kit”) for research use and...

Our engineer, Tatsuya Shima, will give a poster presentation at the 50th annual conference of the Society for Chemistry and Micro-Nano...

BioPhenoMA, Inc. (Shinjuku-Ku, Tokyo, Representative Director Daisuke Niwa, CEO Naoto Fujii) raised 190 million JPY from WASEDA...

We have entered into a research agreement with Chase Therapeutics (Washington D.C., USA), a startup focused on drug discovery, to develop...

A research collaboration with a Japanese manufacturer has been initiated for a blood biomarker test reagent for Alzheimer's disease....

We will be participating in BioJapan2024 and will have a booth and a presentation. Event Details: - BioJapan2024 will take place from...

Naoto Fujii, our CEO, is scheduled to take the stage from 4:22 p.m.. This event is a startup pitch event hosted by eathkey Inc.. You can...